Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WCM Partners is an investment management firm founded by Neil Woodford and Craig Newman, established to focus on the life sciences, healthcare, and technology sectors. The firm was launched following the closure of Woodford Investment Management and aimed to provide advisory services for high-growth, innovative companies. WCM Partners notably collaborated with the US-based Acacia Research to manage a portfolio of biotech and healthcare assets, including significant holdings in companies such as Oxford Nanopore Technologies and BenevolentAI. The firm's strategy centers on identifying undervalued intellectual property and supporting the commercialization of disruptive medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Woodford Capital Management.